{
    "Trade/Device Name(s)": [
        "CellSearch\u00ae Circulating Tumor Cell Kit"
    ],
    "Submitter Information": "Veridex, LLC",
    "510(k) Number": "K103502",
    "Predicate Device Reference 510(k) Number(s)": [
        "K073338"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQI"
    ],
    "Summary Letter Date": "November 23, 2010",
    "Summary Letter Received Date": "November 29, 2010",
    "Submission Date": "November 23, 2010",
    "Regulation Number(s)": [
        "21CFR866.6020"
    ],
    "Regulation Name(s)": [
        "Immunomagnetic Circulating Cancer Cell Selection and Enumeration system"
    ],
    "Analyte Class(es)": [
        "cancer molecular",
        "immunology"
    ],
    "Analyte(s)": [
        "Circulating tumor cells (CTC)",
        "EpCAM",
        "cytokeratins 8, 18, 19",
        "CD45"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "CellTracks\u00ae AutoPrep\u00ae System",
        "MagNest\u00ae",
        "CellTracks Analyzer II",
        "CellSpotter\u00ae Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Immunomagnetic capture",
        "Immunofluorescence"
    ],
    "Methodologies": [
        "Cell selection and enumeration",
        "Immunomagnetic separation",
        "Fluorescent microscopy"
    ],
    "Submission Type(s)": [
        "Kit",
        "Reagent",
        "Analyzer",
        "System",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for CellSearch Circulating Tumor Cell Kit for immunomagnetic selection and enumeration of circulating tumor cells in whole blood from patients with metastatic breast, colorectal, or prostate cancer",
    "Indications for Use Summary": "Intended for enumeration of circulating tumor cells of epithelial origin in whole blood to aid in monitoring and prognosis assessment in patients with metastatic breast, colorectal, or prostate cancer",
    "fda_folder": "Immunology"
}